Organization
Akdeniz University, Antalya, Turkey
2 abstracts
Abstract
ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).Org: Sarah Cannon Research Institute/Tennessee Oncology, Jilin Cancer Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Federal State Budgetary Institution “N. N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Beijing Cancer Hospital,
Abstract
A MULTINATIONAL STUDY OF THROMBOTIC MICROANGIOPATHY IN MACROPHAGE ACTIVATION SYNDROME: A DREADFUL CONDITION WHICH IS LIKELY UNDER-RECOGNIZEDOrg: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy, Istituto G. Gaslini, Genova, Italy, Università degli Studi di Genova, Genova, Italy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Università degli Studi di Messina, Messina, Italy,